GH
LAB icon

GAM Holding’s Standard BioTools LAB Stock Holding History

GAM Holding’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,800
Closed -$455K – 1149
2015
Q1 		$455K Sell
10,800
-29,200
-73% -$1.15M 0.01% 858
2014
Q4 		$1.35M Hold
40,000
– – 0.02% 625
2014
Q3 		$980K Buy
+40,000
New +$1.12M 0.01% 717

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GAM Holding's LAB Position: Q2 2015 in Review

GAM Holding sold out of Standard BioTools (LAB) in Q2 2015, closing a stake of 10,800 shares — an estimated $455K sold.

GAM Holding first reported a position in LAB in Q3 2014 and held it in 3 quarters. The position peaked at $1.35M in Q4 2014. 107 funds tracked by Wall St. Rank hold LAB as of Q2 2015.

  • GAM Holding reported no remaining Standard BioTools position as of Q2 2015 after selling out during the quarter.
  • GAM Holding sold 10,800 Standard BioTools shares in Q2 2015, an estimated $455K.
  • GAM Holding first reported a position in Standard BioTools in Q3 2014 and held it in 3 quarters.
  • GAM Holding's Standard BioTools position peaked at $1.35M in Q4 2014.
  • 107 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2015.

Based on GAM Holding's 13F filing for Q2 2015, filed 27 Jul 2015.